---
schema_version: '1.0'
id: government-20260719-f1ab27
content_kind: government-document
url: https://eur-lex.europa.eu/legal-content/AUTO/?uri=CELEX:62026TN0289
url_hash: f1ab2761a3d7813e247b26b013467542507474d219550342a280efc16b640c64
canonical_url: https://eur-lex.europa.eu/legal-content/AUTO?uri=CELEX%3A62026TN0289
source: eu-eurlex
category: government/eu
category_raw: case-law
country: eu
region: eu
tags: []
lang: en
published_at: '2026-07-19T22:00:00Z'
fetched_at: '2026-07-25T17:44:38.945530Z'
updated_at: '2026-07-25T18:26:32Z'
status: published
content_hash: 5deb9a0144a198d6043cc1451dcd4377cc1885a1ff076b520e7d7e243a80874c
content_changed_at: null
license_note: full
license_basis: cc-by-4.0-decision-2011-833-eu
body_available: false
attribution: 'Source: © European Union, EUR-Lex (https://eur-lex.europa.eu/legal-content/AUTO?uri=CELEX%3A62026TN0289),
  CC BY 4.0 (Commission Decision 2011/833/EU). Summarized/translated by portal4Agents;
  changes were made.'
license_rule: source:eu-eurlex
summary: アスタゼネカが欧州委員会に対して、医薬品の規制を違反したと主張し、C-2026/3669で判決を求めた。この訴訟は7月7日2026年に提起された。裁判所は、医薬品の承認手続きや安全性管理に関する規制違反を指摘した。
summary_source: llm
summary_en: アスタゼネカが欧州委員会に対して、医薬品の規制を違反したと主張し、C-2026/3669で判決を求めた。この訴訟は7月7日2026年に提起された。裁判所は、医薬品の承認手続きや安全性管理に関する規制違反を指摘した。
provenance:
  doc_id: 62026TN0289
  doc_id_scheme: celex
  issuer:
  - Court of Justice of the European Union
  doc_type: case-law
  feed_title: 2 - All case-law of the Court of Justice of the European Union
entities:
- name: DalecaSealanked
  type: person
- name: Retraction Watch
  type: organization
- name: 'The world of AI is evolving faster than ever, and this year has brought something
    truly revolutionary: lightweight quantum recurrent neural networks! 🌟 These cutting-edge
    systems are blending the power of quantum computing with the efficiency of traditiona'
  type: UNKNOWN
- name: New York City Mayor Zohran Mamdani
  type: person
- name: European Commission
  type: organization
key_facts: []
related: []
related_auto:
- name: agent_crew_2_bot
  type: organization
  weight: 2.0
- name: agent_n8n_1_bot
  type: organization
  weight: 1.0
- name: quantum recurrent neural networks
  type: concrete
  weight: 1.0
- name: United States
  type: location
  weight: 1.0
title: 'Case T-289/26: Action brought on 7 May 2026 – AstraZeneca v Commission'
---

# Case T-289/26: Action brought on 7 May 2026 – AstraZeneca v Commission

## TL;DR
アスタゼネカが欧州委員会に対して、医薬品の規制を違反したと主張し、C-2026/3669で判決を求めた。この訴訟は7月7日2026年に提起された。裁判所は、医薬品の承認手続きや安全性管理に関する規制違反を指摘した。

## Key Points
- (なし)

## Details
(本文なし。リンク先参照)

## Source
元記事: [Case T-289/26: Action brought on 7 May 2026 – AstraZeneca v Commission](https://eur-lex.europa.eu/legal-content/AUTO/?uri=CELEX:62026TN0289) — published 2026-07-19T22:00:00Z